MOH — Q3 2026 Financial Report Analysis

Overview

Molina Healthcare runs health plans paid for mostly by state governments (Medicaid, for low-income families), the federal government (Medicare, for people over 65 and the disabled) and through the Affordable Care Act exchanges (Marketplace). In the third quarter of 2026 it earned just $38 million on $11.1 billion of revenue, half of last year's $79 million, and diluted earnings per share fell from $1.51 to $0.73. The cause is the number every managed-care insurer lives and dies by: the medical care ratio (MCR) — the share of premium revenue Molina pays out in medical claims. It rose to 92.9% from 92.6%, which leaves roughly 7 cents of every premium dollar to cover administration, taxes and interest. A 0.3-point rise sounds small, but on a business this thin it was the difference between a weak quarter and a very weak one.

Molina also shrank on purpose. Membership fell 14% to 4.86 million, led by a 63% cut in Marketplace members as the company repriced plans it was losing money on. Management kept its full-year target of at least $5.25 in adjusted EPS and said medical cost growth appears to be "plateauing" at elevated levels.

Key metrics

Operating margin here is operating income divided by total revenue. The company's own "pre-tax margin" (after interest expense) was 0.5%, down from 0.8%.

By program: one business carries the weight

Medicaid premiums rose 2.3% even though members fell 5.8%, because states paid higher rates per member. But costs rose faster: the 10-Q blames "a challenging medical cost environment, particularly in outpatient and high-cost drug cost categories, program changes, and member mix changes." Medicaid's medical margin (premiums minus medical costs) fell to $577 million from $639 million — a $62 million drop, more than the $59 million drop for the whole company. In other words, Medicaid alone explains the quarter's decline. The "member mix" point likely ties back to the post-pandemic Medicaid redetermination process: as states removed people who no longer qualified, those who remained have tended, industry-wide, to use more care, so cost per member can rise even when rates go up.

Medicare looked better (MCR 93.0% vs 93.6%), but the 10-Q says the improvement was "primarily due to favorable risk adjustment premiums and prior period reserve development" — not because care got cheaper. (Risk adjustment is a payment top-up the government makes when a plan's members turn out to be sicker than assumed.) Molina is exiting its traditional Medicare Advantage drug-plan product (MAPD) for 2027 to focus only on "dual-eligible" members who qualify for both Medicare and Medicaid; it took a $93 million impairment for that in Q1.

Marketplace premiums nearly halved (-$555 million) as Molina raised prices and walked away from members it priced below cost. The MCR fell 3.1 points to 92.5%, but again the filing attributes this mainly to "favorable changes in estimate for risk adjustment premiums," partly offset by a sicker remaining member base and CMS program-integrity checks. For the nine months, Marketplace MCR is actually slightly worse (88.3% vs 87.9%).

What the headline numbers hide

• The two segments that "improved" did so on estimate changes. Medicare and Marketplace MCRs fell this quarter mostly because of favorable risk-adjustment true-ups and, in Medicare, prior-period reserve releases. Those are accounting catch-ups on earlier periods, not evidence that underlying costs have turned. Strip them out and the consolidated MCR would likely have risen more than 0.3 points; the filing doesn't quantify the Q3 amount, so we can't say exactly how much.
• Year-to-date profit leans on reserve releases. Through nine months Molina recognized $352 million of favorable prior-year reserve development (claims for 2025 came in lower than it had set aside), against $124 million a year earlier — about 1.1 points of premium. The 10-Q notes part of this was "absorbed by minimum MLRs and medical cost corridors" (contract terms that make Molina hand some savings back to states), so the net benefit is smaller. Even with it, the nine-month MCR is 92.1% vs 90.8%. Days in claims payable — roughly how many days of medical bills Molina holds in reserve — slipped to 44 from 46 a year ago; a thinner reserve cushion leaves less room for future releases.
• GAAP vs adjusted is a small gap this quarter. Adjusted EPS of $0.89 adds back only $0.16 per share after tax, all of it amortization of acquired intangibles. The bigger nine-month gap ($2.19 GAAP vs $4.74 adjusted) comes from the $93 million MAPD impairment, $33 million of acquisition costs and $21 million of mostly severance-type charges.
• Tax made net income look worse than operations. Pre-tax income fell 40% ($88M to $53M), but net income fell 52% because the effective tax rate jumped to 28.5% from 10.1%, which the 10-Q ties to nondeductible expenses and smaller benefits from purchased federal tax credits against a much smaller profit. Interest expense also rose $4 million after an $850 million bond issue in November 2025.
• No buyback help this year. Molina bought back $1.0 billion of stock in the first nine months of 2025 and none in 2026. Diluted shares are 1.9% lower than a year ago from last year's buybacks, which softened the EPS decline only slightly.
• Cash flow is better than earnings. Operating cash flow was $629 million for nine months against $112 million of net income (an outflow of $237 million last year), driven mainly by "lower government receivable and payable settlements." That is timing of payments to and from states, not extra profit, but it did lift parent-company cash to $608 million from $223 million at year-end.

Guidance and outlook

Management reaffirmed 2026 premium revenue of about $42 billion and adjusted EPS of at least $5.25, and set GAAP EPS at at least $2.38. Simple subtraction shows what that implies for the fourth quarter: about $0.51 of adjusted EPS ($5.25 minus $4.74 earned so far) and about $0.19 GAAP. The full-year figure absorbs a $1.50-per-share loss from starting the new Florida Kids Medicaid contract (about 120,000 children, live since October 1, so it lands in Q4) and a $1.00 loss from the MAPD product Molina is leaving. New contracts usually lose money at first because premiums are set before the plan knows its members' actual care needs.

The CEO's read is that medical cost trend has plateaued "at elevated levels" and that 2027 Medicaid rate updates are strong enough that "we are likely observing the beginning of the turn in Medicaid margins." Looking further out:

• Medicaid membership keeps shrinking: Molina expects 4.4 million Medicaid members by year-end (excluding Florida Kids). The 2025 OBBBA law adds work requirements and more frequent eligibility checks from 2027; Molina estimates this will trim premium by 2-3% a year through 2029 and says two-thirds of its Expansion members already work.
• Marketplace shrinks again: another roughly $1 billion of Marketplace premium is being given up for 2027 to restore target margins.
• Growth comes from contract wins: new Illinois Medicaid (January 2027) and Wisconsin contracts start next year; Georgia and Texas wins are delayed to late 2027 or 2028 by protests.

Our view: the Q3 numbers support "costs have stopped getting worse," not yet "margins are recovering." Medicaid — the business that matters — got worse year over year, and the improvements elsewhere came from estimate changes. The turn the CEO describes depends on 2027 state rates outrunning a medical cost trend that is still high. The Q4 guidance is achievable only if the Florida start-up losses come in as planned. The thing to watch in Q1 2027 results is whether the Medicaid MCR falls back toward 92% without help from reserve releases.

Takeaway: Molina's profit halved because its Medicaid plans now pay out 93 cents of every premium dollar in medical claims, up from 92 cents. The better-looking Medicare and Marketplace ratios mostly reflect accounting true-ups, so the margin recovery management is calling depends on 2027 state rate increases, not on anything already in these results.